Autoplaque vs TruPlan

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)
VS
by Circle Cardiovascular Imaging Inc.

AI Verdict

Autoplaque specializes in the AI-powered quantitative analysis of coronary plaques and luminal stenoses for heart attack risk prediction. TruPlan, conversely, is an AI-enabled tool specifically for pre- and post-procedural planning of Left Atrial Appendage Closure (LAAC) procedures. While both leverage AI for cardiac CT imaging, their distinct clinical applications make them adjacent rather than direct competitors.

Choose Autoplaque if…

Choose Autoplaque if your primary need is to quantitatively analyze coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for assessing a patient's overall atherosclerotic burden, predicting heart attack risk, and guiding medical treatment strategies for coronary artery disease. It provides detailed characterization of plaque and stenosis for comprehensive risk stratification.

View Autoplaque →

Choose TruPlan if…

Choose TruPlan if your focus is on comprehensive pre-procedural planning and post-procedural follow-up specifically for Left Atrial Appendage Closure (LAAC) procedures. This software excels in providing AI-enabled left heart segmentation, automated LAA landing zone definition, and various simulation tools (TEE, ICE, Fluoroscopic) to optimize device selection and placement for LAAC interventions.

View TruPlan →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque TruPlan
Deployment Workstation-based post-processing application, runs on Windows or Mac OS. Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

TruPlan

TruPlan emphasizes user-friendliness with explicit mentions of 'intuitive controls,' 'simple and user friendly,' 'easy to use,' and 'drag and drop' features, alongside MacOS compatibility. While Autoplaque is described as an 'interactive tool' with reviewable and editable segmentations, its documentation does not highlight ease of use as strongly.

Clinical Value

TruPlan

Both tools are FDA-cleared and offer significant clinical value in their respective specialties. Autoplaque provides quantitative plaque analysis for heart attack risk prediction, backed by extensive peer-reviewed research. TruPlan, however, demonstrates a more direct and quantifiable impact on procedural efficiency and outcomes for Left Atrial Appendage Closure (LAAC) procedures, with reported reductions in devices used, procedural time, and increased capacity.

Pricing & Value

TruPlan

TruPlan offers greater pricing transparency, including potential no-cost access through Boston Scientific representatives and a flexible subscription model for its broader cvi42 platform. It also highlights clear reimbursement opportunities for AI-enabled plaque analysis with CPT code 75577. Autoplaque's pricing is not disclosed, making it difficult to assess its financial value proposition.

Enterprise Readiness

TruPlan

TruPlan explicitly states HIPAA compliance and has a Business Associate Agreement (BAA), along with ISO 13485:2016 and MDSAP certifications, indicating a robust framework for enterprise deployment and regulatory adherence. Its on-premise server deployment option also supports better integration into hospital IT infrastructure. Autoplaque lacks explicit statements on BAA/HIPAA compliance, and its workstation-based deployment may be less scalable for large enterprises.

Innovation

TruPlan

Both are innovative AI tools. Autoplaque excels in automated, quantitative plaque analysis for broad cardiovascular risk prediction, including the characterization of dangerous plaque. TruPlan stands out with its comprehensive AI-enabled procedural planning and multi-modal simulations (TEE, ICE, Fluoroscopic), including a 'first-to-market ICE simulator,' offering a more integrated and advanced solution for a complex interventional procedure.

Support & Docs

TruPlan

TruPlan provides clear support channels, including an email address and the ability to create support tickets, along with a comprehensive list of documentation such as user manuals, installation guides, and release notes. Additionally, it benefits from field support through Boston Scientific's clinical and sales representatives. Autoplaque lacks specific details on dedicated support channels and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque TruPlan
Tool Name Autoplaque TruPlan
Company Cedars-Sinai Medical Center: AIM Circle Cardiovascular Imaging
Primary Application Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images Pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures
Key Feature Example 1 AI-powered quantitative analysis of atherosclerotic plaque AI-enabled Left Heart Segmentation
Key Feature Example 2 Automated vessel, plaque, and lumen segmentation Automated LAA Landing Zone Definition

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and TruPlan.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque is designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. TruPlan, on the other hand, is an AI-enabled CT imaging software specifically for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures.
Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses, including automated vessel, plaque, and lumen segmentation. TruPlan offers AI-enabled Left Heart Segmentation, Automated LAA Landing Zone Definition, 3D Anatomical Assessment, and simulations for TEE, ICE, and Fluoroscopic rendering.
Autoplaque is designed for use by Cardiology and Radiology specialists. TruPlan supports Cardiology, Cardiothoracic Surgery, and Radiology, reflecting its focus on LAAC procedures.
AI Tool Finder
AI-powered search. Results may not be comprehensive.